Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment January 10, 2025
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics December 3, 2024
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion November 21, 2024
ExxonMobil Announces Licensing Agreement to Expand Proprietary Rebar Processing Technology to Global Markets November 1, 2024
